Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Non-invasive detection of pancreatic cancer by measuring DNA methylation of Basonuclin 1 and Septin 9 in plasma

20 Apr 2019

Abstract excerpt

To the Editor: Pancreatic cancer (PC), a deadly malignancy with an overall 5-year survival rate of 5% to 15%, is ranked as the seventh leading cause of cancer death in the world in spite of its low occurrence rate.[1,2] Early detection appears to be the most effective approach to improve the overall survival of patients with PC. However, the difficulty in early detection of PC is a lack of specific symptoms and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Epigenetics and DNA Methylation
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31205116
DOI: 10.1097/cm9.0000000000000257

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Non-invasive detection of pancreatic cancer by measuring DNA methylation of Basonuclin 1 and Septin 9 in plasmaPMID 31205116Read ↗

Early detection of pancreatic cancer: Where are we now and where are we going?Semantic proximity Read ↗

The clinical utility of biomarkers in the management of pancreatic adenocarcinoma.Semantic proximity Read ↗

Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNASemantic proximity Read ↗

Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer.Semantic proximity Read ↗

Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in bloodSemantic proximity Read ↗

Current State of “Omics” Biomarkers in Pancreatic CancerSemantic proximity Read ↗

Deciphering DNA methylation signatures of pancreatic cancer and pancreatitisSemantic proximity Read ↗

Progress on molecular markers of pancreatic cancerSemantic proximity Read ↗

Liquid biopsy in pancreatic cancer: the beginning of a new eraSemantic proximity Read ↗

Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers’ DiscoverySemantic proximity Read ↗

Genome-Wide Analysis of Cell-Free DNA Methylation Profiling for the Early Diagnosis of Pancreatic CancerSemantic proximity Read ↗

Analysis of the mRNA Expression of Peripheral Blood Stem and Progenitor Cell Markers in Pancreatic Neoplastic DisordersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.